Olga Grzybowska-Izydorczyk Selected Research

Olga Grzybowska-Izydorczyk Research Topics

6	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 12/2016 - 12/2006
5	Hematologic Neoplasms (Hematological Malignancy) 07/2021 - 02/2008
4	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 04/2024 - 08/2017
4	Neoplasms (Cancer) 01/2023 - 02/2008
3	Leukemia 01/2023 - 07/2017
3	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 01/2021 - 02/2008
2	Lymphoma (Lymphomas) 07/2021 - 09/2013
2	Multiple Myeloma 07/2021 - 09/2013
1	Leukocytosis (Pleocytosis) 01/2023
1	Fibrosis (Cirrhosis) 01/2023
1	Primary Myelofibrosis (Myelosclerosis) 01/2023
1	Hemorrhage 08/2017
1	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 09/2013
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 03/2013
1	Disease Progression 03/2013
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2008
1	Hypersensitivity (Allergy) 08/2007

3	Imatinib Mesylate (Gleevec)FDA Link 04/2024 - 07/2017
3	Inhibitor of Apoptosis ProteinsIBA 01/2021 - 02/2008
3	Cladribine FDA LinkGeneric 01/2020 - 08/2007
2	Tyrosine Kinase InhibitorsIBA 04/2024 - 01/2022
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2015
2	SurvivinIBA 01/2015 - 02/2008
2	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 03/2013 - 12/2012
2	Interleukin-10 (Interleukin 10)IBA 03/2013 - 12/2012
1	Syntex adjuvant formulationIBA 01/2023
1	Reticulin (Reticular Fiber)IBA 01/2023
1	ruxolitinibIBA 01/2023
1	ponatinibIBA 01/2022
1	NF-kappa B (NF-kB)IBA 01/2021
1	CaspasesIBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2020
1	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2020
1	InterferonsIBA 08/2017
1	Messenger RNA (mRNA)IBA 12/2016
1	CytokinesIBA 08/2015
1	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 08/2015
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 08/2015
1	Cytotoxins (Cytolysins)IBA 03/2012
1	Phosphotransferases (Kinase)IBA 03/2012
1	Antineoplastic Agents (Antineoplastics)IBA 03/2012
1	aspartyllysineIBA 12/2009
1	Rituximab (Mabthera)FDA Link 08/2007
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 08/2007
1	Bortezomib (Velcade)FDA Link 12/2006
1	Monoclonal AntibodiesIBA 12/2006

2	Hematopoietic Stem Cell Transplantation 07/2021 - 09/2013
1	Therapeutics 01/2022
1	Cesarean Section (Caesarean Section) 08/2017
1	Drug Therapy (Chemotherapy) 09/2013